Melanoma Institute Australia joins forces with Wollongong Wolves in the fight against melanoma
6 February 2017
The world’s largest melanoma-specific treatment and research facility, Melanoma Institute Australia, is joining forces with the Wollongong Wolves Football Club in the battle to reduce Australia’s melanoma rates.
CEO of Melanoma Institute Australia, Carole Renouf, announced the partnership at a function in Wollongong in support of Wolves’ legend David Cervinski who is battling melanoma.
Ms Renouf said the partnership between MIA and the Wollongong Wolves would help promote sun safe behaviour amongst Wolves’ players and also spread the life-saving message to family and fans.
“It is crucial that young Australians take steps now to protect their skin from sun damage,” Ms Renouf said. “Intense, intermittent sun exposure leading to sunburn, especially before puberty, significantly increases your risk of developing melanoma in the future.
“The real tragedy of melanoma is that it is largely preventable, so we are delighted to be working with the Wollongong Wolves from the grass roots level to change behaviour and save lives.”
CEO of Wollongong Wolves Football Club Chris Papakosmas said, “Partnering with Melanoma Institute Australia is one of the most important sponsorships for our club. Following on from David Cervinski’s recent battles we thought this was a great way to raise awareness.”
One Australian dies from melanoma every six hours. Melanoma is the most common cancer affecting 15-39 year-old Australians and the leading cause of cancer death in 20-39 year-olds. The incidence of melanoma in the over 60s is also high, a legacy of sun-damage from decades ago.
As part of the partnership, Melanoma Institute Australia’s logo will feature prominently on the 2017 jerseys of all Wollongong Wolves juniors. There will also be ongoing education, sun-safety and fundraising campaigns, including the Wolves involvement in MIA’s annual Melanoma March fundraising event at Wollongong’s Stuart Park on Sunday 12 March.
“This partnership is crucial in tackling melanoma head on,” said Ms Renouf. “We are delighted to be working with the Wollongong Wolves and together help end melanoma for future generations.”
Wolves’ fans can join the fight against melanoma by participating in Melanoma March Wollongong on Sunday 12 March. To register, go to www.melanomamarch.org.au
Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.
When David lost his life last year, he was 33, with three daughters under six.
Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.
Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology.
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.
An American study has discovered a link between early detection and marital status in melanoma diagnosis.
An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.
Professor Richard Scolyer highlights the difficulties of diagnosis following the Australian Story feature program on Emma Betts.
Cancer Australia releases 'stage at diagnosis' data for top five incidence cancers – including melanoma
For the first time in Australia, national data has been released on cancer stage at diagnosis. This data explores the top five incidence cancers – female breast cancer, colorectal, lung, prostate cancers and melanoma.
'Dear Emma' - a tribute to the life and times of a young woman determined to raise awareness about melanoma.
Carole Renouf, CEO for MIA thanks Toyota for helping fuel ongoing melanoma research.
Fraser Dykes tackled the Kokoda Trail on an eight day trek in memory of his friend Mark 'Bod' Boddison.
Harvard’s Clinical Professor Martin Mihm and MIA’s Conjoint Medical Director Professor Richard Scoyler delivered a series of lectures on melanoma pathology in Vancouver, British Colombia this week at the world’s biggest annual pathology meeting.
A round of applause for a well deserved win.
A message from our CEO, Carole Renouf
Piction, Brisbane, Bahturst and Port Macquarie march to end melanoma.
Australian researchers have greater clarity on the best course of treatment for patients with advanced melanoma which has spread to the brain.
Melanoma treatment has come a long way in recent times, and the role that nurses play caring for melanoma patients has changed dramatically too.